pith. sign in

arxiv: 2502.20112 · v2 · submitted 2025-02-27 · ⚛️ physics.med-ph · physics.ins-det

Monte Carlo simulation of the ISOLPHARM gamma camera for Ag-111 imaging

D. Serafini , A. Leso , A. Arzenton , S. Spadano , E. Borciani , D. Chen , C. Sbarra , M. Negrini
show 6 more authors
A. Margotti N. Lanconelli G. Baldazzi E. Mariotti S. Corradetti A. Andrighetto
This is my paper

Pith reviewed 2026-05-23 02:39 UTC · model grok-4.3

classification ⚛️ physics.med-ph physics.ins-det
keywords Monte Carlo simulationGeant4gamma cameraAg-111spatial resolutionsensitivitypreclinical imagingtargeted radionuclide therapy
0
0 comments X

The pith

A Monte Carlo model of the ISOLPHARM gamma camera estimates 4 mm spatial resolution and 19 cps/MBq sensitivity for Ag-111 imaging.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper builds a Geant4 simulation to test the performance of a gamma camera intended to image the gamma emissions from Ag-111, a radionuclide under development for targeted cancer therapy. The simulation places the detector in conditions that approximate living tissue and calculates how well it can separate tumor signals from surrounding activity. If the model holds, the camera meets the minimum requirements for preclinical use by resolving activity ratios as low as 4 to 1. This matters for researchers who need an affordable imaging tool to track new radiopharmaceuticals without immediate access to clinical-grade scanners.

Core claim

The Geant4 Monte Carlo simulation of the ISOLPHARM gamma camera yields an estimated spatial resolution of approximately 4 mm and sensitivity of 19 cps/MBq, with the system capable of resolving lesions at a 4:1 lesion-to-background activity ratio under in-vivo-like conditions, supporting its suitability for cost-effective preclinical radiopharmaceutical studies.

What carries the argument

The Geant4 Monte Carlo simulation that tracks particle interactions through the modeled detector geometry, materials, and physics processes to generate performance estimates.

If this is right

  • The simulated metrics set quantitative targets for prototype construction and testing.
  • The camera design can support repeated imaging sessions in small-animal studies of Ag-111 uptake.
  • Performance numbers provide a baseline for comparing this device against other preclinical gamma cameras.
  • The simulation framework can be reused to test adjustments to collimator or crystal thickness before hardware changes.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • Validated simulation results could shorten the iteration cycle when adapting the same camera concept to other radionuclides with similar gamma energies.
  • The 4 mm resolution and 4:1 contrast threshold imply the device might also serve as a low-cost option for initial biodistribution checks in early-phase human trials if scaled appropriately.
  • Connecting the simulation output directly to dosimetry models would allow prediction of imaging dose burden alongside therapeutic effect.

Load-bearing premise

The chosen Geant4 physics lists and detector geometry definitions produce results that match what a physical copy of the camera would measure.

What would settle it

Side-by-side measurement of spatial resolution and sensitivity on the actual assembled ISOLPHARM gamma camera using a calibrated Ag-111 source.

read the original abstract

Targeted Radionuclide Therapy (TRT) is a well-established technique for cancer treatment. In this approach, radionuclides are bound to specific drugs that selectively transport them to the tumor site. Within the ISOLPHARM project, a radiopharmaceutical for TRT based on the innovative radionuclide Ag-111 is currently under development. Ag-111 has a half-life of 7.45 days and decays by emitting both electrons and gamma-rays. The emission of gamma-rays, predominantly at an energy of 342 keV, enables the visualization of Ag-111 using a gamma camera. In this work, we describe a Monte Carlo simulation developed to optimize the design parameters of such an imaging device. The simulation is based on the Geant4 toolkit, which accurately models the interactions between particles and matter. The estimated spatial resolution and sensitivity of the system are approximately 4 mm and 19 cps/MBq, respectively. The simulated device is able to resolve lesions with a lesion-to-background activity ratio of 4:1 under in-vivo-like conditions. These results indicate that the proposed gamma camera can provide cost-effective imaging capabilities for preclinical radiopharmaceutical studies.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

2 major / 1 minor

Summary. The manuscript presents a Geant4 Monte Carlo simulation of a gamma camera optimized for imaging Ag-111 (primarily 342 keV gamma emission) in the context of the ISOLPHARM targeted radionuclide therapy project. It reports simulated performance metrics of approximately 4 mm spatial resolution and 19 cps/MBq sensitivity, along with the ability to resolve lesions at a 4:1 lesion-to-background activity ratio under in-vivo-like conditions, and concludes that the design offers cost-effective preclinical imaging capabilities.

Significance. If the Geant4 model were shown to accurately reproduce experimental behavior at 342 keV, the work would provide a useful starting point for design optimization of a dedicated camera for a novel radionuclide. The simulation-only nature of all quantitative claims, however, means the reported numbers cannot yet be treated as reliable predictors of physical-device performance.

major comments (2)
  1. [Abstract / Results] Abstract and (presumed) Results section: All headline performance figures (4 mm resolution, 19 cps/MBq sensitivity, lesion visibility at 4:1 ratio) are stated as direct outputs of a specific Geant4 geometry and physics-list choice, yet the manuscript supplies neither a benchmark of the same code against measured spectra, point-spread functions, or sensitivity values from any real Anger or CZT system at 342 keV, nor error bars on the extracted metrics. Because these numbers are the sole basis for the claim that the camera “can provide cost-effective imaging capabilities,” the absence of validation is load-bearing.
  2. [Methods] Methods section: No description is given of the Geant4 physics lists, optical-photon transport parameters, crystal light-yield model, or exact collimator and detector geometry definitions. Without these details the simulation cannot be reproduced or assessed for systematic bias in the reported resolution and sensitivity values.
minor comments (1)
  1. [Abstract] The abstract states numerical results without indicating how spatial resolution and sensitivity were extracted from the simulated data (e.g., FWHM of line profiles, count-rate normalization).

Simulated Author's Rebuttal

2 responses · 1 unresolved

We thank the referee for their constructive comments on our simulation study. We address the major comments point by point below, indicating planned revisions where appropriate.

read point-by-point responses

  1. Referee: [Abstract / Results] Abstract and (presumed) Results section: All headline performance figures (4 mm resolution, 19 cps/MBq sensitivity, lesion visibility at 4:1 ratio) are stated as direct outputs of a specific Geant4 geometry and physics-list choice, yet the manuscript supplies neither a benchmark of the same code against measured spectra, point-spread functions, or sensitivity values from any real Anger or CZT system at 342 keV, nor error bars on the extracted metrics. Because these numbers are the sole basis for the claim that the camera “can provide cost-effective imaging capabilities,” the absence of validation is load-bearing.

    Authors: We agree that the work is a pure Monte Carlo simulation study and provides no experimental benchmarks or validation data at 342 keV. The reported figures are outputs of the specific Geant4 model. We will revise the abstract, results, and conclusions to explicitly qualify all metrics as simulated estimates (e.g., “simulated spatial resolution of approximately 4 mm”) and to moderate the final claim to reflect the simulation-only nature. Statistical uncertainties from the Monte Carlo simulations will be added as error bars on the extracted metrics. An experimental benchmark is outside the scope of this design-optimization paper. revision: partial

  2. Referee: [Methods] Methods section: No description is given of the Geant4 physics lists, optical-photon transport parameters, crystal light-yield model, or exact collimator and detector geometry definitions. Without these details the simulation cannot be reproduced or assessed for systematic bias in the reported resolution and sensitivity values.

    Authors: We acknowledge that the current Methods section lacks the necessary implementation details for reproducibility. In the revised manuscript we will expand this section to fully specify the Geant4 physics lists, optical-photon transport parameters, crystal light-yield model, and the precise collimator and detector geometry definitions. revision: yes

standing simulated objections not resolved
  • Provision of experimental validation or benchmark data at 342 keV, as the manuscript is limited to simulation results and no corresponding physical measurements are available.

Circularity Check

0 steps flagged

No circularity in Monte Carlo simulation outputs

full rationale

The paper reports direct Geant4 Monte Carlo simulation results for gamma camera performance metrics (spatial resolution, sensitivity, lesion visibility). No analytic derivations, parameter fittings to data, self-citations, or ansatzes are present that would reduce any claim to its inputs by construction. Results are simulation outputs under stated model assumptions; the lack of experimental benchmark is a validity concern, not circularity.

Axiom & Free-Parameter Ledger

0 free parameters · 1 axioms · 0 invented entities

The central claim rests on the assumption that the chosen Geant4 physics models and detector geometry accurately represent real gamma-ray interactions and camera response. No free parameters or invented entities are described in the abstract.

axioms (1)
  • domain assumption Geant4 physics lists correctly model electromagnetic interactions of 342 keV gamma rays with the detector materials and collimator.
    The performance estimates depend on the fidelity of the standard Geant4 electromagnetic physics processes invoked for this energy range.

pith-pipeline@v0.9.0 · 5802 in / 1234 out tokens · 30808 ms · 2026-05-23T02:39:14.352615+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Lean theorems connected to this paper

Citations machine-checked in the Pith Canon. Every link opens the source theorem in the public Lean library.

What do these tags mean?
matches
The paper's claim is directly supported by a theorem in the formal canon.
supports
The theorem supports part of the paper's argument, but the paper may add assumptions or extra steps.
extends
The paper goes beyond the formal theorem; the theorem is a base layer rather than the whole result.
uses
The paper appears to rely on the theorem as machinery.
contradicts
The paper's claim conflicts with a theorem or certificate in the canon.
unclear
Pith found a possible connection, but the passage is too broad, indirect, or ambiguous to say the theorem truly supports the claim.

Reference graph

Works this paper leans on

28 extracted references · 28 canonical work pages

  1. [1]

    Blachot,Nuclear data sheets for a = 111,Nuclear Data Sheets110(2009) 1239

    J. Blachot,Nuclear data sheets for a = 111,Nuclear Data Sheets110(2009) 1239

    work page 2009

  2. [2]

    Yamamoto, J

    S. Yamamoto, J. Kataoka, T. Oshima, Y. Ogata, T. Watabe, H. Ikeda et al.,Development of a high resolution gamma camera system using finely grooved gagg scintillator,Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment821(2016) 28. [3]Guidance for Preclinical Studies with Radiopharma...

    work page 2016

  3. [3]

    Van Audenhaege, R

    K. Van Audenhaege, R. Van Holen, S. Vandenberghe, C. Vanhove, S.D. Metzler and S.C. Moore, Review of spect collimator selection, optimization, and fabrication for clinical and preclinical imaging,Medical Physics42(2015) 4796 [https://aapm.onlinelibrary.wiley.com/doi/pdf/10.1118/1.4927061]

    work page doi:10.1118/1.4927061 2015

  4. [4]

    Weber and M

    D.A. Weber and M. Ivanovic,Ultra-high-resolution imaging of small animals: Implications for preclinical and research studies,Journal of Nuclear Cardiology6(1999) 332

    work page 1999

  5. [5]

    V. Bom, M. Goorden and F. Beekman,Comparison of pinhole collimator materials based on sensitivity equivalence,Physics in Medicine & Biology56(2011) 3199

    work page 2011

  6. [6]

    Keller,Optimum dimensions of parallel-hole, multi-aperture collimators for gamma-ray cameras,Journal of Nuclear Medicine9(1968) 233

    E.L. Keller,Optimum dimensions of parallel-hole, multi-aperture collimators for gamma-ray cameras,Journal of Nuclear Medicine9(1968) 233

    work page 1968

  7. [7]

    Lucchini, V

    M. Lucchini, V. Babin, P. Bohacek, S. Gundacker, K. Kamada, M. Nikl et al.,Effect of mg2+ ions co-doping on timing performance and radiation tolerance of cerium doped gd3al2ga3o12 crystals, Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment816(2016) 176

    work page 2016

  8. [8]

    Vallabhajosula,Radioactivity detection: Pet and spect scanners, inMolecular Imaging and Targeted Therapy: Radiopharmaceuticals and Clinical Applications, (Cham), pp

    S. Vallabhajosula,Radioactivity detection: Pet and spect scanners, inMolecular Imaging and Targeted Therapy: Radiopharmaceuticals and Clinical Applications, (Cham), pp. 63–86, Springer International Publishing (2023), DOI

    work page 2023

  9. [9]

    Makek, D

    M. Makek, D. Bosnar, A.M. Kožuljević and L. Pavelić,Investigation of gagg:ce with tofpet2 asic readout for applications in gamma imaging systems,Crystals10(2020) . – 8 –

    work page 2020

  10. [10]

    J.Y. Yeom, S. Yamamoto, S.E. Derenzo, V.C. Spanoudaki, K. Kamada, T. Endo et al.,First performance results of ce:gagg scintillation crystals with silicon photomultipliers,IEEE Transactions on Nuclear Science60(2013) 988

    work page 2013

  11. [11]

    M. Niu, Z. Liu, Z. Kuang, X. Wang, N. Ren, Z. Sang et al.,Ultra-high-resolution depth-encoding small animal pet detectors: Using gagg and lyso crystal arrays,Medical Physics49(2022) 3006 [https://aapm.onlinelibrary.wiley.com/doi/pdf/10.1002/mp.15606]

    work page doi:10.1002/mp.15606 2022

  12. [12]

    Yamamoto, T

    K. Yamamoto, T. Nagano, R. Yamada, T. Ito and Y. Ohashi,Recent development of mppc at hamamatsu for photon counting applications, inProceedings of the 5th International Workshop on New Photon-Detectors (PD18), Journal of the Physical Society of Japan, Nov., 2019, DOI

    work page 2019

  13. [13]

    Agostinelli, J

    S. Agostinelli, J. Allison, K. Amako, J. Apostolakis, H. Araujo, P. Arce et al.,Geant4—a simulation toolkit,Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment506(2003) 250

    work page 2003

  14. [14]

    Allison, K

    J. Allison, K. Amako, J. Apostolakis, H. Araujo, P. Arce Dubois, M. Asai et al.,Geant4 developments and applications,IEEE Transactions on Nuclear Science53(2006) 270

    work page 2006

  15. [15]

    Allison, K

    J. Allison, K. Amako, J. Apostolakis, P. Arce, M. Asai, T. Aso et al.,Recent developments in geant4, Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment835(2016) 186

    work page 2016

  16. [16]

    dserafini/gamma-camera

    “dserafini/gamma-camera.”https://github.com/dserafini/gamma-camera, accessed on 16 February 2025

    work page 2025

  17. [17]

    Y. Gao, B. Tang, G. Ji, K. Chen, Z. Wang and H. Ye,A camouflage coating with similar solar spectrum reflectance to leaves based on polymeric inorganic composite,Materials Research Express 8(2021) 066404

    work page 2021

  18. [18]

    Uchida, H

    N. Uchida, H. Takahashi, M. Ohno, T. Mizuno, Y. Fukazawa, M. Yoshino et al.,Attenuation characteristics of a ce:gd3al2ga3o12 scintillator,Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment986(2021) 164725

    work page 2021

  19. [19]

    Brun and F

    R. Brun and F. Rademakers,Root — an object oriented data analysis framework,Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment389(1997) 81

    work page 1997

  20. [20]

    G. Landi,Properties of the center of gravity as an algorithm for position measurements,Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment485(2002) 698

    work page 2002

  21. [21]

    4d moby and ncat phantoms for medical imaging simulation of mice and men

    W. Segars and B. Tsui, “4d moby and ncat phantoms for medical imaging simulation of mice and men.”https://jnm.snmjournals.org/content/48/supplement_2/203P.4, 2007

    work page 2007

  22. [22]

    Segars, B.M

    W. Segars, B.M. Tsui, E.C. Frey, G. Johnson and S.S. Berr,Development of a 4-d digital mouse phantom for molecular imaging research,Molecular Imaging & Biology6(2004) 149

    work page 2004

  23. [23]

    Wieczorek and A

    H. Wieczorek and A. Goedicke,Analytical model for spect detector concepts,IEEE Transactions on Nuclear Science53(2006) 1102–1112

    work page 2006

  24. [24]

    Berger, J

    M. Berger, J. Hubbell, S. Seltzer, J. Chang, J. Coursey, R. Sukumar et al., 2010. 10.18434/T48G6X

    work page doi:10.18434/t48g6x 2010

  25. [25]

    Castiglioni, G

    I. Castiglioni, G. Rizzo, M. Gilardi, V. Bettinardi, A. Savi and F. Fazio,Lesion detectability and quantificationinpet/ctoncologicalstudiesbymontecarlosimulations,IEEETransactionsonNuclear Science52(2005) 136. – 9 –

    work page 2005

  26. [26]

    Systems - molecubes

    “Systems - molecubes.”https://www.molecubes.com/systems/, accessed on 23 January 2026

    work page 2026

  27. [27]

    U-spect | microspect from milabs

    “U-spect | microspect from milabs.”https://www.milabs.com/u-spect/, accessed on 23 January 2026

    work page 2026

  28. [28]

    Crawford, A.K.H

    J.R. Crawford, A.K.H. Robertson, H. Yang, C. Rodríguez-Rodríguez, P.L. Esquinas, P. Kunz et al., Evaluation of 209at as a theranostic isotope for 209at-radiopharmaceutical development using high-energy spect,Physics in Medicine & Biology63(2018) 045025. – 10 –

    work page 2018